Amdocs Limited officer and director Shimie Hortig filed a Form 144 notice of proposed sale on November 13, 2026, covering 1,733 ordinary shares acquired through a restricted stock award vesting on November 11, 2026.

Key Highlights

  • Filer: Shimie Hortig, listed as both an officer and a director of Amdocs Limited.
  • Shares proposed for sale: 1,733 ordinary shares with an aggregate market value of $71,850.18, according to the filing.
  • Acquisition: The shares were acquired on November 11, 2026, through the vesting of a restricted stock award from Amdocs Limited, with no cash consideration paid.
  • Approximate date of sale: November 11, 2026, through broker Morgan Stanley Smith Barney LLC on Nasdaq.
  • Total shares outstanding: The filing reports 102,833,225 ordinary shares outstanding.
  • Prior three-month sales: The filing reports nothing to report for securities sold in the past three months.

Hortig's Proposed Sale of Restricted Stock Award Shares at Amdocs

According to the filing, Shimie Hortig submitted a Form 144 notice to the U.S. Securities and Exchange Commission on November 13, 2026, in connection with a proposed sale of ordinary shares of Amdocs Limited (NASDAQ:DOX). The filing identifies Hortig as both an officer and a director of the company, whose registered address is Hirzel House, Smith Street, St. Peter Port, Guernsey.

The 1,733 ordinary shares covered by the notice were acquired on November 11, 2026, through the vesting of a restricted stock award granted by Amdocs Limited. The filing states the nature of payment as "No consideration; shares acquired pursuant to a restricted stock award." The aggregate market value of the shares proposed for sale is listed as $71,850.18. The proposed sale is to be executed through Morgan Stanley Smith Barney LLC, located at 1 New York Plaza, New York, NY 10004, on Nasdaq.

The filing discloses that Hortig had no securities sales to report during the three months preceding this notice. As of the filing, the total number of Amdocs ordinary shares outstanding is reported as 102,833,225. By signing the Form 144, the filer represented, as stated in the notice, that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed."

What Was Disclosed

Amdocs officer and director Shimie Hortig filed a Form 144 on November 13, 2026, proposing to sell 1,733 ordinary shares with an aggregate market value of $71,850.18, acquired via a restricted stock award vesting on November 11, 2026, with no prior sales in the past three months.